1-4 of 4
Lauren Diebold
Close
Sort by
Journal Articles

The Chromosome 21 Kinase DYRK1A Controls Cell Cycle Exit and Survival During Lymphoid Development and Is a Novel Therapeutic Target In Acute Lymphoblastic Leukemia

Benjamin J. Thompson, MD, PhD, Lauren Diebold, Sebastien Malinge, PhD, Bertrand Leblond, Anne-Sophie Casagrande, Laurent Désiré, Alicia Foucourt, Thierry Besson, Nobuko Hijiya, MD, John D. Crispino, PhD
Journal: Blood
Blood (2013) 122 (21): 814.
https://doi.org/10.1182/blood.V122.21.814.814
Published: 2013
Journal Articles

Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling

Sébastien Malinge, Clarisse Thiollier, Timothy M. Chlon, Louis C. Doré, Lauren Diebold, Olivier Bluteau, Vinciane Mabialah, William Vainchenker, Philippe Dessen, Susan Winandy, Thomas Mercher, John D. Crispino
Journal: Blood
Blood (2013) 121 (13): 2440–2451.
https://doi.org/10.1182/blood-2012-08-450627
Published: 2013
Includes: Supplemental data
Journal Articles

Ikaros Is a GATA Switch Target Gene That Restrains Megakaryopoiesis In Part by Blocking Notch Signaling.

Sebastien Malinge, PhD, Clarisse Thiollier, Timothy M Chlon, Louis C Dore, Lauren Diebold, Susan Winandy, PhD, Thomas Mercher, PhD, John Crispino, PhD
Journal: Blood
Blood (2010) 116 (21): 1602.
https://doi.org/10.1182/blood.V116.21.1602.1602
Published: 2010
Journal Articles

Development of a Mouse Model of DS Megakaryoblastic Leukemia and Identification of the Hsa21 Gene DYRK1A as a Prominent Contributor to DS-AMKL

Sebastien Malinge, PhD, Gina Kirsammer, PhD, Meghan Bliss-Moreau, Timothy M Chlon, Lauren Diebold, Stella T Chou, MD, Mitchell Weiss, MD, Sandeep Gurbuxani, MBBS, PhD, John Crispino, PhD
Journal: Blood
Blood (2010) 116 (21): 469.
https://doi.org/10.1182/blood.V116.21.469.469
Published: 2010